Relationship between SARS‐CoV‐2 vaccination and cases, program breakthrough cases, and deaths in Dois Vizinhos, Paraná, Brazil

Author:

Vasconcelos Marina Wust12,de Barros Flavia Regina Oliveira234,Pilonetto Jéssica Cousseau12,Rosa Schelder Gabriel Bertoncello2,Gonçalves Sandrieli12,Kuhn Betty Cristiane23,De Assis Leite Deborah Catharine125,Perseguini Juliana Morini Küpper Cardoso2,Gabiatti Naiana Cristine12,Wendt Simone Neumann26,Ghisi Nédia de Castilhos12ORCID

Affiliation:

1. Programa de Pós‐Graduação em Biotecnologia—PPGBIOTEC Universidade Tecnológica Federal do Paraná Dois Vizinhos Paraná Brazil

2. Laboratório Multiusuário de Análises Biológicas e Biologia Molecular (BioMol)—UTFPR Grupo de Pesquisa em Biologia Molecular—UTFPR Dois Vizinhos Paraná Brazil

3. Coordenação do curso de Engenharia de Bioprocessos e Biotecnologia Universidade Tecnológica Federal do Paraná Curitiba Paraná Brazil

4. Programa de Pós‐Graduação em Zootecnia (PPZ) Universidade Tecnológica Federal do Paraná Dois Vizinhos Paraná Brazil

5. Programa de Pós‐Graduação em Tecnologias Computacionais para o Agronegócio‐PPGTCA Universidade Tecnológica Federal do Paraná Medianeira Paraná Brazil

6. Coordenação do Curso de Engenharia Florestal Universidade Tecnológica Federal do Paraná Curitiba Paraná Brazil

Abstract

AbstractSeveral vaccines have been produced in 2 years of the COVID‐19 pandemic to control the infection outbreak. This study demonstrated the success of vaccination in controlling COVID‐19 cases and deaths in a small city (41 424 people) with a low population density in Brazil. This study was based on a 1‐year dataset since the application of the first dose in January 2021. The results show a reduction in positive cases and deaths as the vaccination coverage increased in the city, mainly after 15 000 inhabitants were vaccinated (35.21% of the population) in July 2021. At the time, 49.06% of administered vaccines were ChAdOx1‐S recombinant, 39.80% inactivated SARS‐CoV‐2 virus (CZ02 strain), 9.70% Tozinameran, and 1.44% Ad26.COV2‐S recombinant. From August 2021, a marked reduction in daily positive cases and deaths was observed, and incidence (≤2.49 per 1000 inhabitants) and mortality (≤0.02 per 1000 inhabitants) rates remained stabilized until January 2022, when a new outbreak occurred upon the emergence of the Omicron variant. However, the mortality rate (0.07 per 1000 inhabitants) remained low regardless of the Omicron high incidence rate (68.41 per 1000 inhabitants). These data demonstrate the COVID‐19 vaccination effectiveness with a threshold of 35.21% of the population vaccinated in this city model.

Funder

Rotary Foundation

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference21 articles.

1. VelavanTP MeyerCGThe COVID‐19 epidemic.2020.doi:10.1111/tmi.13383

2. The COVID-19 Vaccination Strategy in Brazil—A Case Study

3. Brasil. Plano nacional de vacinação contra a COVID‐19. Ministério da Saúde. 2021;10:118. Accessed October 11 2022.https://drive.google.com/file/d/1kjtbgnf9QNmdRloqSod0Tx9uUB9IFhMV/view%0Ahttps://sbim.org.br/images/files/notas-tecnicas/pno-covid-decima-edicao.pdf

4. WHO coronavirus disease (COVID‐19) dashboard with vaccination data | WHO coronavirus (COVID‐19) dashboard with vaccination data;World Health Organization;World Heal Organ,2021

5. IBGE. Dois Vizinhos (PR) | Cidades e Estados | IBGE. Accessed October 14 2022.https://www.ibge.gov.br/cidades-e-estados/pr/dois-vizinhos.html. Published 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3